Charles E Mahan

Summary

Publications

  1. ncbi Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis
    Charles E Mahan
    University of New Mexico Health Sciences Center, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Clin Appl Thromb Hemost 18:45-58. 2012
  2. ncbi New antithrombotics: the impact on global health care
    Charles E Mahan
    University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87111, USA
    Thromb Res 127:518-24. 2011
  3. ncbi Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event
    Charles E Mahan
    University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
    Thromb Haemost 106:405-15. 2011
  4. ncbi Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates
    Charles E Mahan
    New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico 87102, USA
    Thromb Haemost 108:291-302. 2012
  5. ncbi Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitals
    Charles E Mahan
    New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
    Thromb Res 130:586-90. 2012
  6. ncbi Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing
    Charles E Mahan
    Cardinal Health Pharmacy Solutions, Lovelace Medical Center, Lovelace Rehabilitation Hospital, Lovelace Health Systems, 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM, 87102, USA
    Intern Emerg Med 5:299-306. 2010

Detail Information

Publications6

  1. ncbi Venous thromboembolism pharmacy intervention management program with an active, multifaceted approach reduces preventable venous thromboembolism and increases appropriate prophylaxis
    Charles E Mahan
    University of New Mexico Health Sciences Center, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 0001, USA
    Clin Appl Thromb Hemost 18:45-58. 2012
    ..0006). In conclusion, a pharmacy-led multifaceted intervention can significantly increase the rates of appropriate prophylaxis and significantly reduce the incidence of preventable VTE in hospitalized patients...
  2. ncbi New antithrombotics: the impact on global health care
    Charles E Mahan
    University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87111, USA
    Thromb Res 127:518-24. 2011
    ..Clinicians should be vigilant concerning these agents and be prepared to inform patients and make decisions with their use...
  3. ncbi Deep-vein thrombosis: a United States cost model for a preventable and costly adverse event
    Charles E Mahan
    University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
    Thromb Haemost 106:405-15. 2011
    ..8 to $52 billion, $6.8 to $36 billion, and $3.4 to $27 billion, respectively...
  4. ncbi Venous thromboembolism: annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates
    Charles E Mahan
    New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico 87102, USA
    Thromb Haemost 108:291-302. 2012
    ..The cost models may be utilised to estimate other countries' costs or VTE-specific disease states...
  5. ncbi Regulatory, policy and quality update for venous thromboembolism and stroke in United States hospitals
    Charles E Mahan
    New Mexico Heart Institute, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, USA
    Thromb Res 130:586-90. 2012
    ..This review provides a brief history, overview, and update for the development of quality measures, quality systems, and regulatory and policy changes as related to stroke and VTE within the US healthcare system...
  6. ncbi Venous thromboembolism prophylaxis with unfractionated heparin in the hospitalized medical patient: the case for thrice daily over twice daily dosing
    Charles E Mahan
    Cardinal Health Pharmacy Solutions, Lovelace Medical Center, Lovelace Rehabilitation Hospital, Lovelace Health Systems, 601 Dr Martin Luther King Jr Ave NE, Albuquerque, NM, 87102, USA
    Intern Emerg Med 5:299-306. 2010
    ..Newly published risk-assessment models may be beneficial in determining which patients would best benefit from BID UFH or TID UFH...